Innoviva, Inc. (INVA)
20.50
-0.05
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
20.51
+0.01
(+0.05%)
After-Hours: 20:00
Innoviva Gross Profit Margin (Quarterly) : 73.64% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.64% |
| March 31, 2026 | 74.75% |
| December 31, 2025 | 64.05% |
| September 30, 2025 | 67.87% |
| June 30, 2025 | 80.12% |
| March 31, 2025 | 79.58% |
| December 31, 2024 | 81.98% |
| September 30, 2024 | 78.51% |
| June 30, 2024 | 82.21% |
| March 31, 2024 | 74.16% |
| December 31, 2023 | 74.10% |
| September 30, 2023 | 71.47% |
| June 30, 2023 | 79.38% |
| March 31, 2023 | 77.91% |
| December 31, 2022 | 75.28% |
| September 30, 2022 | 87.14% |
| June 30, 2022 | 96.78% |
| March 31, 2022 | 96.26% |
| December 31, 2021 | 96.89% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | -84.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 95.36% |
| Collegium Pharmaceutical, Inc. | 55.18% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 32.64% |
| Return on Assets | 22.50% |
| Return on Invested Capital | 25.11% |
| Profit Margin (Quarterly) | -67.80% |
| Operating Margin (Quarterly) | 41.33% |
| Return on Net Operating Assets | 97.18% |